Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2005
04/21/2005WO2005034986A1 Remedy for kidney diseases
04/21/2005WO2005034985A1 Agent for improving mental disorders
04/21/2005WO2005034984A1 Cd44 splice variant in diagnosis and therapy of intestinal cancer
04/21/2005WO2005034983A1 Filamentous haemagglutinin in the treatment and/or prophylaxis of immune-mediated disorders
04/21/2005WO2005034982A1 Cyclic peptide antitumor agents
04/21/2005WO2005034981A1 Dipeptide phenyl ethers
04/21/2005WO2005034980A1 Glutamine for use in treating injury
04/21/2005WO2005034979A2 Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity
04/21/2005WO2005034978A2 MEDICAL USE OF IKKϵ OR OF INHIBITORS THEREOF
04/21/2005WO2005034944A1 Combinations of indole compounds and alkylating agents for the treatment of cancer
04/21/2005WO2005034881A2 Methods and compositions for treating conditions involving abnormal angiogenesis
04/21/2005WO2005034876A2 Use of cell lines to produce active therapeutic proteins
04/21/2005WO2005034860A2 Thiol reactive agents as a therapeutic modality
04/21/2005WO2005034858A2 Compositions and methods for treatment of muscle pain and muscle wasting
04/21/2005WO2005034856A2 Targeted drug-formaldehyde conjugates and methods of making and using the same
04/21/2005WO2005034844A2 Exosite-directed thrombin inhibitors
04/21/2005WO2005034842A2 Peptides useful as hiv fusion inhibitors
04/21/2005WO2005034737A2 Methods for diagnosing and treating endoplasmic reticulum (er) stress diseases
04/21/2005WO2005034733A2 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
04/21/2005WO2005023857A3 Agent derived from tortoise spleen stimulating mammalian hemopoiesis
04/21/2005WO2005020928A3 Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
04/21/2005WO2005019427A3 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals
04/21/2005WO2005018664B1 Method and cosmetic product containing beta-endorphin, which are intended to limit fatty tissue growth
04/21/2005WO2005017160A3 Mobilization of hematopoietic cells
04/21/2005WO2005016365A3 Liquid, aqueous pharmaceutical composition of factor vii polypeptides
04/21/2005WO2005011721A3 Use of a pak inhibitor for the treatment of a joint disease
04/21/2005WO2005003296A3 Albumin fusion proteins
04/21/2005WO2005000891A3 Thrombopoietin proteins with improved properties
04/21/2005WO2005000339A8 Melanocortin receptor 4(mc4) agonists and their uses
04/21/2005WO2005000239A3 Lyase treatment for p. carinii
04/21/2005WO2004105782A3 Drug delivery systems for tumor targeting ngr-molecules and uses thereof
04/21/2005WO2004104199A3 Modulation of gene expression using dna-dna hybrids
04/21/2005WO2004100973A3 Pharmaceutical compositions of antithrombin iii for the treatment of retroviral diseases.
04/21/2005WO2004096268A3 Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
04/21/2005WO2004094608A3 Human procolipase like nucleic acids and polypeptides and their methods of use threof
04/21/2005WO2004090112B1 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
04/21/2005WO2004089982A3 April variants and methods thereof
04/21/2005WO2004083388A3 Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
04/21/2005WO2004078918A3 Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides
04/21/2005WO2004073649A3 Clk-peptide and slk-peptide
04/21/2005WO2004071462A3 Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction
04/21/2005WO2004069992A3 Oligomeric compounds for the modulation of ras expression
04/21/2005WO2004056080A9 Endothelial cell specifically binding peptides
04/21/2005WO2004053103A3 METHOD OF INTRODUCING siRNA INTO ADIPOCYTES
04/21/2005WO2004052273A3 Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands
04/21/2005WO2004041203A3 Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
04/21/2005WO2004041194A3 Inhibition of hiv-1 replication
04/21/2005WO2004020588A3 Transferrin fusion protein libraries
04/21/2005WO2004020581A3 Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr7 genes
04/21/2005WO2004018628A3 Charged peptide-amphiphile solutions & self-assembled peptide nanofiber networks formed therefrom
04/21/2005WO2004011623A3 Antisense modulation of ptpra expression
04/21/2005WO2003105753A3 Targeted enzymes and methods of making and using targeted enzymes.
04/21/2005WO2003090598A3 Apparatus and methods for enzymatic escharotomy in burn induced compartment syndrome
04/21/2005WO2003070189A3 Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
04/21/2005WO2003061559A3 Binding peptides specific for the extracellular domain of erbb2 and uses therefor
04/21/2005WO2003049673A3 Methods and compositions for control of bone formation via modulation of sympathetic tone
04/21/2005WO2003040330A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
04/21/2005WO2003016478A3 G-protein coupled receptor polynucleotides and methods of use thereof
04/21/2005WO2002098348A3 Glp-1 formulations with protracted time action
04/21/2005WO2002092842A3 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
04/21/2005WO2002092841A3 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
04/21/2005WO2002057425A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
04/21/2005US20050086711 Transgenic animals and methods for screening for anti-amyloidogenic agents and agents for treating neurodegenerative disease
04/21/2005US20050086707 Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
04/21/2005US20050085758 Dilute aqueous solution containing epidermal growth factor in gel
04/21/2005US20050085629 Utilization of FPRL1 as a functional receptor by serum amyloid A (SAA)
04/21/2005US20050085627 Nucleotide sequences coding histone methyltransferase for use in identifying modulators for treatment and prevention of asthma disorders
04/21/2005US20050085623 Bioactive amino acid sequences conjugated with biocompatible, biodegradable delivery system for use in treatment and prevention of bone disorders: prosthetics
04/21/2005US20050085553 Remedies for mild recognition deflict
04/21/2005US20050085548 Administering mixture of arginine and reductase inhibitase; therapy for endothelial cell diseases; hypotensive agents; cardiovascular disorders brain disorders
04/21/2005US20050085517 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
04/21/2005US20050085425 Novel peptidomimetic NS3-serine protease inhibitors of hepatitis C virus
04/21/2005US20050085424 Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof
04/21/2005US20050085423 Administering an amide ciompound ; analgesics; antiinflamamtory agents
04/21/2005US20050085422 Peptides derived from colostrinin
04/21/2005US20050085420 Method of modulating apoptosis and compositions thereof
04/21/2005US20050085418 Ligands for TGF-beta binding proteins and uses thereof
04/21/2005US20050085416 Stabilized albumin, fatty acid complex; anticancer agents; bactericides
04/21/2005US20050085415 Nanoparticles injected directly into eye; integrin receptor antagonist; angiogenesis inhibitor, polypeptide
04/21/2005US20050085414 Novel medical use for tachykinin antagonists
04/21/2005US20050085412 Hydrosilation of follicle stimulating hormone; efficiency
04/21/2005US20050085411 A peptidomimetic as an antiproliferative agent
04/21/2005US20050085408 Drugs ameliorating hypo-hdl cholesterolemia
04/21/2005US20050084969 Method for producing a recombinant polypeptide
04/21/2005US20050084936 Human regulatory proteins
04/21/2005US20050084935 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/21/2005US20050084911 DNA molecules encoding imidazoline receptive polypeptides and polypeptides encoded thereby
04/21/2005US20050084903 Lectin protein prepared from maackia fauriei, process for preparing the same and the use thereof
04/21/2005US20050084900 Mammalian cell membrane proteins; related reagents
04/21/2005US20050084897 DNA encoding human vanilloid receptor VR3
04/21/2005US20050084885 Modified transcription factor protein for use as tool in prevention and treatment of cell proliferative disorder
04/21/2005US20050084876 Flip genes and flip proteins
04/21/2005US20050084873 Polypeptide compounds for inhibiting angiogenesis and tumor growth
04/21/2005US20050084859 Herbicide metabolizing proteins; ferredoxins; methylation, dehydrogenation; kits
04/21/2005US20050084850 Stromal cell protein for use as tool in stimulating blood production in patients undergoing chemotherapy
04/21/2005US20050084573 Process for prolonging the after-harvest life of citrus fruit
04/21/2005US20050084538 Ultrasonic concentration of drug delivery capsules
04/21/2005US20050084537 Sustained-release compositions
04/21/2005US20050084534 Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
04/21/2005US20050084518 For producing beautiful skin and improving constipation, reducing hair loss
1 ... 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 ... 3163